Sort
48,018 grants matching “immunotherapy”
Thymic and peripheral regulation of autoreactive T cells by coreceptor therapy
$388,750Roland Michael Tisch · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI
Metabolic Control of T Cell Senescence in Pathogenesis and Immunotherapy of Alzheimer's Disease
$388,750Guangyong Peng · Washington University · R01 · FY2024 · AG
Metabolic Control of T Cell Senescence in Pathogenesis and Immunotherapy of Alzheimer's Disease
$388,750Guangyong Peng · Washington University · R01 · FY2023 · AG
Thymic and peripheral regulation of autoreactive T cells by coreceptor therapy
$388,750Roland Michael Tisch · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AI
Activation, Phenotype and Function of CD4 T Cells in Schistosoma-Pulmonary Hypertension
$388,750Brian Barkley Graham · University Of Colorado Denver · R01 · FY2017 · HL
Excessive lipid metabolism in T cell senescence and immunosuppression
$388,750Guangyong Peng · Washington University · R01 · FY2025 · AI
Thymic and peripheral regulation of autoreactive T cells by coreceptor therapy
$388,750Roland Michael Tisch · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AI
Nanoformulated small molecule immunotherapy for SHH medulloblastoma
$388,750Marina Sokolsky-Papkov · Univ Of North Carolina Chapel Hill · R01 · FY2023 · NS
The role of AIM2 in T cell-mediated autoimmunity
$388,750Roland Michael Tisch · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AI
Activation, Phenotype and Function of CD4 T Cells in Schistosoma-Pulmonary Hypertension
$388,750Brian Barkley Graham · University Of Colorado Denver · R01 · FY2019 · HL
An Adjuvanted Therapeutic DNA Vaccine for AIDS
$388,734Powderject Vaccines, Inc. · P01 · FY2003 · AI
Project 2
$388,732David A Barbie · Dana-Farber Cancer Inst · P50 · FY2024 · CA
EBV-Specific T-Cell Therapy for Nasopharynx Cancer: Immunomodulation and Response
$388,730Marshall R Posner · Dana-Farber Cancer Inst · R21 · FY2008 · CA
Oral Pathogens and Dendritic Cell Subsets
$388,717Christopher W Cutler · State University New York Stony Brook · R01 · FY2009 · DE
Allergen T cell epitopes and phenotypes during peanut immunotherapy
$388,682Erik Wambre · Benaroya Research Inst At Virginia Mason · U19 · FY2022 · AI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
$388,676Joseph John Barchi · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
T cell repertoire of graft-versus-host disease and graft-versus-tumor effects
$388,635Thea Friedman · Hackensack University Medical Center · R01 · FY2011 · CA
T cell repertoire of graft-versus-host disease and graft-versus-tumor effects
$388,635Robert Korngold · Hackensack University Medical Center · R01 · FY2012 · CA
Bacterial and Liposomal Antigen Processing
$388,575Clifford V Harding · Case Western Reserve University · R01 · FY2010 · AI
Recognition of Self and Mutated Self by Autoimmune and Tumor-Specific TCRs
$388,575Roy A Mariuzza · Univ Of Maryland, College Park · R01 · FY2010 · AI
Elucidating the Function of PKC-theta in Alloreactivity and GVHD
$388,526Amer Aziz Beg · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · AI
Molecular mechanisms of signaling co-ordination in innate lymphocytes
$388,516Subramaniam Malarkannan · Medical College Of Wisconsin · R01 · FY2014 · AI
Role of Ly6K in TGF-beta and immune escape pathways of triple negative breast cancer
$388,498Geeta Upadhyay · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2022 · CA
An In Situ Patient-specific Chemo-Immunotherapy for Skin Cancers
$388,443Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2013 · CA
Core C: Patient Derived Xenograft (PDX)/ Syngeneic Mouse Core
$388,439Gatien Moriceau · University Of California Los Angeles · P01 · FY2021 · CA